Clinical efficacy of betaloc combining Tongxinluo Capsules in patients with angina pectoris of coronary heart disease
WANG Xiao-bing
ZHANG Wei
WU Yun-tao
YAO Lu
LIU Hui
Abstract：Objective To study the clinical efficacy of betaloc combining Tongxinluo Capsules in patients with angina pectoris of coronary heart disease (CHD).Methods The patients (n=80) were chosen from Aug. 2013 to Mar. 2015, and randomly divided into observation group and control group (eachn=40). The control group was given routine therapy, and observation group was additionally given betaloc combining Tongxinluo Capsules. The curative effect and incidence of adverse reactions were compared in 2 groups.Results The effective rate was 97.50% in observation group and 82.50% in control group (P<0.01). There were 2 patients (5.00%) with adverse reactions in observation group and 3 (7.50%) in control group (P>0.05).Conclusion Betaloc combining Tongxinluo Capsules has ideal curative effect in the treatment of angina pectoris of CHD, and will not increase the incidence of adverse reactions.
Keywords：Tongxinluo CapsulesBetalocAngina pectoris of coronary heart disease
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：2( 696-697 )